Contents

119 Editor’s Choice June 2012: Scales for measuring everything DIANA N. J. LOCKWOOD

Editorials

121 The importance of neglected tropical diseases in sustaining leprosy programmes W.C.S. SMITH,
D.S. ODONG AND A.N. OGOSI

124 ‘Double mainstreaming’: including people affected by leprosy in poverty reduction programmes
M. GRIFFITHS

127 An overview of training and development needs J. EBENSO

Review

129 Empowerment Assessment tools in People with Disabilities in Developing Countries. A systematic
literature review L. BAKKER AND W.H. VAN BRAKEL

Original Papers

154 A comparison of the change in clinical severity scale score and a retrospective physician
assessment of neurological outcome in individuals with leprosy associated nerve function
impairment after treatment with corticosteroids S.L. WALKER, P.G. NICHOLLS, S. DHAKAL,
R.A. HAWKSWORTH, M. MACDONALD, K. MAHAT, S. RUCHAL, S. HAMAL, D.A. HAGGE, K.D. NEUPANE AND D.N.J. LOCKWOOD

164 Bacteriological results and leprosy reactions among MB leprosy patients treated with Uniform
Multidrug Therapy in China J. SHEN, N. BATHYALA, A. KROEGER, B. ARANA, V. PANNIKAR, H. MOU,
X. BAO, R. YANG, P. MANICKAM, W. LI, M. ZHOU AND J. WANT

172 Limitations in activities of people affected by leprosy after completing multidrug therapy:
application of the SALSA scale S.M.T. NARDI, V.D. PASCHOAL AND D.M.T. ZANETTA

184 Patterns and trends of leprosy in Mexico: 1989–2009 M.R. LARREA, M.C. CARREÑO AND P.E. FINE

195 Prevalence and characteristics of neuropathic pain in the people affected by leprosy
in China S. CHEN, J. QU AND T. CHU

Case Report

202 Borderline-lepromatous leprosy manifesting as granulomatous mastitis D. PANDHI, P. VERMA,
S. SHARMA AND A.K. DHAWAN

Workshop Report

205 The prevention of leprosy related disability as an integral component of the
government health delivery programme in Myanmar H. CROSS

218 PADMA SHRI AWARD